바이러스 게놈 시퀀싱 시장 보고서(2026년)

Viral genome sequencing is a laboratory method for determining the complete nucleotide sequence of a virus's genetic material, whether DNA or RNA. This process allows researchers to read the virus's entire genome, identify the virus, analyze its structure and function, detect mutations, and track genetic changes over time.

The key sequencing technologies of viral genome sequencing include next-generation sequencing, Sanger sequencing, and third-generation sequencing. Next-generation sequencing enables rapid, high-throughput analysis of viral genomes to detect mutations, track outbreaks, and support public health responses. Sample types include blood, nasal or throat swabs, saliva, and others. Applications include clinical diagnostics, research, epidemiology, vaccine development, and more, serving hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end users.

Tariffs have affected the viral genome sequencing market by increasing the cost of importing high-end sequencing instruments, reagents, and software tools. Segments such as next-generation and third-generation sequencing technologies are most impacted, particularly in regions like North America and Europe that rely heavily on imports. While tariffs raise operational costs, they are encouraging local manufacturing, investment in domestic R&D, and the development of cost-effective sequencing solutions, creating opportunities for market diversification and innovation.

The viral genome sequencing market research report is one of a series of new reports from The Business Research Company that provides viral genome sequencing market statistics, including viral genome sequencing industry global market size, regional shares, competitors with a viral genome sequencing market share, detailed viral genome sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the viral genome sequencing industry. This viral genome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viral genome sequencing market size has grown rapidly in recent years. It will grow from $6.71 billion in 2025 to $7.72 billion in 2026 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to rising prevalence of viral outbreaks, adoption of next-generation sequencing, growth of clinical diagnostics, government funding for research, demand for epidemiological studies.

The viral genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $13.57 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to ai-driven genome analysis, expansion of vaccine development programs, adoption of portable sequencing technologies, integration with predictive bioinformatics, increasing focus on real-time pathogen monitoring. Major trends in the forecast period include high-throughput viral genome sequencing, portable sequencing devices, integration with bioinformatics platforms, automated sample processing, real-time mutation tracking.

The increasing prevalence of infectious diseases is expected to drive the growth of the viral genome sequencing market. Infectious diseases, caused by pathogenic microorganisms, are rising globally due to factors such as international travel, urbanization, and rapid cross-border transmission of pathogens. This growing disease burden has prompted governments and healthcare systems to strengthen genomic surveillance and outbreak response capabilities. Viral genome sequencing is essential for infectious disease management by enabling rapid identification of viral strains, monitoring mutations, tracking transmission pathways, and supporting targeted public health interventions. For example, in February 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, influenza caused approximately 290,000-450,000 hospitalizations and 34,000-53,000 deaths annually in the United States, while RSV accounted for an estimated 190,000-350,000 hospitalizations and 10,000-23,000 deaths. Therefore, the increasing prevalence of infectious diseases is propelling the viral genome sequencing market.

Major companies in the viral genome sequencing market are emphasizing progress in long read sequencing technologies such as benchtop long read sequencing platforms to strengthen their competitive position. A benchtop long read sequencing platform is a compact laboratory system built to produce highly accurate and extended nucleotide reads from viral genomes. This capability allows detailed identification of structural variants, better genome assembly, and quicker processing for pathogen analysis. It also improves surveillance capacity, assists outbreak response efforts, and increases research accuracy, although it requires substantial capital investment and sophisticated data analysis infrastructure for large scale use. For example, in November 2024, Pacific Biosciences, a biotechnology company based in the United States, launched the Revio benchtop HiFi sequencing platform. The system provides high fidelity long reads, higher throughput than earlier platforms, and scalable configuration suitable for both clinical and research laboratories, supporting more effective tracking of viral mutations and more complete genome sequencing in the viral genome sequencing market.

In February 2025, Deerfield Management Company, a US-based investment management firm specializing in healthcare innovation, acquired Singular Genomics Systems for an undisclosed amount. Through this acquisition, Deerfield aims to provide Singular Genomics with enhanced strategic flexibility to advance its next-generation sequencing and spatial multiomics technologies for researchers and clinicians. Singular Genomics is a US-based provider of NGS platforms, including the G4 sequencing platform for genomic sequencing and the developing G4x spatial sequencer for multiomics applications.

Major companies operating in the viral genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Genewiz, Macrogen Inc., MedGenome Labs Ltd., Eurofins Scientific SE, CD Genomics, BGI Genomics Co. Ltd.

North America was the largest region in the viral genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viral genome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral genome sequencing market includes revenues earned by providing services such as whole viral genome sequencing, targeted amplicon sequencing, metagenomic sequencing for pathogen discovery, viral variant analysis and mutation profiling, and bioinformatics data interpretation and phylogenetic analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Genome Sequencing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses viral genome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral genome sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral genome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Sequencing Technology: Next-Generation Sequencing; Sanger Sequencing; Third-Generation Sequencing
• 2) By Sample Type: Blood; Nasal Or Throat Swabs; Saliva; Other Sample Types
• 3) By Application: Clinical Diagnostics; Research; Epidemiology; Vaccine Development; Other Applications
• 4) By End-User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Next-Generation Sequencing: Sequencing By Synthesis; Ion Semiconductor Sequencing; Reversible Terminator Chemistry Sequencing; Targeted Amplicon Sequencing; Whole Genome Shotgun Sequencing
• 2) By Sanger Sequencing: Capillary Electrophoresis Sequencing; Automated Fluorescent Chain Termination Sequencing; Dideoxy Chain Termination Sequencing; Low Throughput Mutation Verification Sequencing; Plasmid Insert Verification Sequencing
• 3) By Third-Generation Sequencing: Single Molecule Real Time Sequencing; Nanopore Based Sequencing; Zero Mode Waveguide Sequencing; Long Read Direct Ribonucleic Acid Sequencing; Real Time Field Deployable Sequencing
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Integrated DNA Technologies Inc.; GenScript Biotech Corporation; Novogene Co. Ltd.; Takara Bio Inc.; Twist Bioscience Corporation; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Genewiz; Macrogen Inc.; MedGenome Labs Ltd.; Eurofins Scientific SE; CD Genomics; BGI Genomics Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Viral Genome Sequencing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Viral Genome Sequencing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Viral Genome Sequencing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Viral Genome Sequencing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 High-Throughput Viral Genome Sequencing
  • 4.2.2 Portable Sequencing Devices
  • 4.2.3 Integration With Bioinformatics Platforms
  • 4.2.4 Automated Sample Processing
  • 4.2.5 Real-Time Mutation Tracking

5. Viral Genome Sequencing Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Research Institutes
• 5.3 Pharmaceutical And Biotechnology Companies
• 5.4 Public Health Agencies
• 5.5 Diagnostic Laboratories

6. Viral Genome Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viral Genome Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Viral Genome Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Viral Genome Sequencing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Viral Genome Sequencing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Viral Genome Sequencing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viral Genome Sequencing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viral Genome Sequencing Market Segmentation

• 9.1. Global Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Next-Generation Sequencing, Sanger Sequencing, Third-Generation Sequencing
• 9.2. Global Viral Genome Sequencing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood, Nasal Or Throat Swabs, Saliva, Other Sample Types
• 9.3. Global Viral Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Diagnostics, Research, Epidemiology, Vaccine Development, Other Applications
• 9.4. Global Viral Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
• 9.5. Global Viral Genome Sequencing Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sequencing By Synthesis, Ion Semiconductor Sequencing, Reversible Terminator Chemistry Sequencing, Targeted Amplicon Sequencing, Whole Genome Shotgun Sequencing
• 9.6. Global Viral Genome Sequencing Market, Sub-Segmentation Of Sanger Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Capillary Electrophoresis Sequencing, Automated Fluorescent Chain Termination Sequencing, Dideoxy Chain Termination Sequencing, Low Throughput Mutation Verification Sequencing, Plasmid Insert Verification Sequencing
• 9.7. Global Viral Genome Sequencing Market, Sub-Segmentation Of Third-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single Molecule Real Time Sequencing, Nanopore Based Sequencing, Zero Mode Waveguide Sequencing, Long Read Direct Ribonucleic Acid Sequencing, Real Time Field Deployable Sequencing

10. Viral Genome Sequencing Market Regional And Country Analysis

• 10.1. Global Viral Genome Sequencing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Viral Genome Sequencing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viral Genome Sequencing Market

• 11.1. Asia-Pacific Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viral Genome Sequencing Market

• 12.1. China Viral Genome Sequencing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viral Genome Sequencing Market

• 13.1. India Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viral Genome Sequencing Market

• 14.1. Japan Viral Genome Sequencing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viral Genome Sequencing Market

• 15.1. Australia Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viral Genome Sequencing Market

• 16.1. Indonesia Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viral Genome Sequencing Market

• 17.1. South Korea Viral Genome Sequencing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viral Genome Sequencing Market

• 18.1. Taiwan Viral Genome Sequencing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viral Genome Sequencing Market

• 19.1. South East Asia Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viral Genome Sequencing Market

• 20.1. Western Europe Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viral Genome Sequencing Market

• 21.1. UK Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viral Genome Sequencing Market

• 22.1. Germany Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viral Genome Sequencing Market

• 23.1. France Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viral Genome Sequencing Market

• 24.1. Italy Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viral Genome Sequencing Market

• 25.1. Spain Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viral Genome Sequencing Market

• 26.1. Eastern Europe Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viral Genome Sequencing Market

• 27.1. Russia Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viral Genome Sequencing Market

• 28.1. North America Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viral Genome Sequencing Market

• 29.1. USA Viral Genome Sequencing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viral Genome Sequencing Market

• 30.1. Canada Viral Genome Sequencing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viral Genome Sequencing Market

• 31.1. South America Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viral Genome Sequencing Market

• 32.1. Brazil Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viral Genome Sequencing Market

• 33.1. Middle East Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viral Genome Sequencing Market

• 34.1. Africa Viral Genome Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Viral Genome Sequencing Market, Segmentation By Sequencing Technology, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viral Genome Sequencing Market Regulatory and Investment Landscape

36. Viral Genome Sequencing Market Competitive Landscape And Company Profiles

• 36.1. Viral Genome Sequencing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Viral Genome Sequencing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Viral Genome Sequencing Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Viral Genome Sequencing Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Genewiz, Macrogen Inc., MedGenome Labs Ltd., Eurofins Scientific SE, CD Genomics, BGI Genomics Co. Ltd.

38. Global Viral Genome Sequencing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Viral Genome Sequencing Market

41. Viral Genome Sequencing Market High Potential Countries, Segments and Strategies

• 41.1 Viral Genome Sequencing Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Viral Genome Sequencing Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Viral Genome Sequencing Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer